Simplifying Global Compliance
FDAnews Device Daily Bulletin
NEW DATA FROM HEARTMATE II PHASE I TRIAL RELEASED AT AMERICAN HEART ASSOCIATION 2005 SCIENTIFIC SESSIONS
Nov. 16, 2005
Thoratec, a world leader in products to treat cardiovascular disease, recently
said that the first major presentation of data from the Phase I trial for its
HeartMate II LVAS (left ventricular assist system) demonstrates encouraging
results in terms of both patient survival and quality of life.
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing